Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis

被引：0
|
作者：
Patricia Pozo-Rosich
Karen H. Samaan
Todd J. Schwedt
Robert A. Nicholson
Mallikarjuna Rettiganti
Eric M. Pearlman
机构：
[1] Vall d’Hebron University Hospital,Headache Unit, Neurology Department
[2] Vall d’Hebron Research Institute,Headache and Neurological Pain Research Group, Department de Medicine
[3] Universitat Autònoma de Barcelona,undefined
[4] Eli Lilly and Company,undefined
[5] LTC-South,undefined
[6] Mayo Clinic,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Chronic; Efficacy; Episodic; Galcanezumab; Migraine; Wear off;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3154 / 3165
页数：11
相关论文
共 50 条
  • [11] Medication overuse in a post-hoc analysis of phase 3 placebo controlled studies of galcanezumab in the prevention of episodic and chronic migraine
    Aurora, Sheena K.
    Morrow, Paula A.
    Ruff, Dustin D.
    Pearlman, Eric
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [12] Annual indirect costs savings in patients with episodic or chronic migraine: a post-hoc analysis of phase 3 galcanezumab clinical trials in the United States
    Varnado, Oralee J.
    Ye, Wenyu
    Mi, Xiaojuan
    Burge, Russel
    Hall, Jerry
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 149 - 157
  • [13] Annual indirect cost savings in patients with episodic or chronic migraine: Post-hoc analyses from multiple galcanezumab clinical trials
    Ford, J. H.
    Tockhorn-Heidenreich, A.
    Nichols, R. M.
    Ye, W.
    Bhandari, R.
    Tobin, J. A.
    Lipton, R. B.
    HEADACHE, 2021, 61 : 54 - 55
  • [14] Annual indirect cost savings in patients with episodic or chronic migraine: post-hoc analyses from multiple galcanezumab clinical trials
    Tobin, Joshua
    Ford, Janet H.
    Tockhorn-Heidenreich, Antje
    Nichols, Russell M.
    Ye, Wenyu
    Bhandari, Rohit
    Mi, Xiaojuan
    Sharma, Karan
    Lipton, Richard B.
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 630 - 639
  • [15] Factors Associated with Significant Reduction in Migraine Headache Days: A Post Hoc Analysis of Phase 3 Placebo-Controlled Trials of Patients with Episodic and Chronic Migraine Treated with Galcanezumab
    Aurora, S.
    Ruff, D.
    Zhang, Q.
    Pearlman, E.
    HEADACHE, 2018, 58 : 163 - 163
  • [16] Medication Overuse in a Post-hoc Analysis of Phase 3 Placebo-controlled Studies of Galcanezumab in the Prevention of Episodic and Chronic Migraine
    Aurora, S. K.
    Ruff, D.
    Pearlman, E. M.
    HEADACHE, 2019, 59 : 23 - 23
  • [17] Factors associated with significant reduction in migraine headache days: a post hoc analysis of phase 3 placebo-controlled trials of patients with episodic and chronic migraine treated with galcanezumab
    Aurora, Sheena K.
    Ruff, Dustin D.
    Zhang, Qi
    Pearlman, Eric M.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [18] Patient Gains in Daily Functioning and Reductions in Disability with Galcanezumab among Patients with Episodic and Chronic Migraine
    Ruff, Dustin
    Ford, Janet
    Starling, Amaal
    Detke, Holland C.
    Nichols, Russell
    Port, Martha
    Aurora, Sheena K.
    NEUROLOGY, 2019, 92 (15)
  • [19] Patient Gains in Daily Functioning and Reductions in Disability with Galcanezumab Among Patients with Episodic and Chronic Migraine
    Ruff, D.
    Ford, J.
    Starling, A. J.
    Detke, H. C.
    Nichols, R.
    Port, M.
    Aurora, S. K.
    HEADACHE, 2019, 59 : 101 - 101
  • [20] Safety and efficacy of galcanezumab in chronic and episodic migraine patients: a systematic review and meta-analysis of randomized controlled trials
    Zaazouee, Mohamed Sayed
    Ebrahim, Rokaya Y.
    Al-araj, Ghaida'a
    Zaki, Ibram
    Saad, Ahmed
    Farhat, Abdullah Mohamed
    Ali, Mustafa Hussein
    Elshennawy, Mohamed
    Fawy, Omar Khaled Fahmy
    Ahmed, Hadi F.
    Alahmad, Ziad
    Nada, Eman Ayman
    Abo-Hamra, Reem I.
    Elsnhory, Ahmed Bostamy
    Eleyan, Mohammed
    AbuEl-Enien, Hazem
    Elromely, Rasha Abdo
    AbdelQadir, Yossef Hassan
    Shah, Jaffer
    Elshanbary, Alaa Ahmed
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2024, 60 (01):
12345